Dr. Dileep R. Yavagal First in South Florida to Use FDA-Approved Stroke Device
On April 4, 58-year-old Jorge Lazo, a smoker with diabetes and high blood pressure, was rushed to a nearby hospital after the entire left side of his body suddenly became paralyzed. When standard treatment failed to improve his condition, Lazo was taken to the University of Miami/Jackson Memorial Hospital, where he found hope in Dileep R. Yavagal, M.D.
After an advanced MRI revealed blockages in Lazo’s right carotid artery and a large area at risk for irreversible stroke damage, Yavagal, director of interventional neurology, co-director of endovascular neurosurgery, and assistant professor of neurology and neurosurgery, sprang into action.
The first physician in South Florida to use the newly FDA-approved Solitaire FR revascularization device, Yavagal inserted it into the femoral artery in Lazo’s groin and, threading it under X-ray guidance into his brain, quickly tugged the blood clots out, restoring blood flow and mobility of his left leg and arm.
“The rapidity and robust effectiveness of this new stroke device represents a major advance from the previously available stroke devices to open blocked arteries in the brain,” Yavagal explained.
Approved in March, the Solitaire FR revascularization device is twice as effective as other devices previously used for acute ischemic stroke, according to results of a clinical study, “Solitaire With the Intention for Thrombectomy.”